Nanoparticles for Glioblastoma Treatment
GBM is the most common and aggressive primary brain tumor in adults, characterized by low survival rates, high recurrence, and resistance to conventional therapies. Traditional diagnostic and therapeutic methods remain limited due to the difficulty in permeating the blood–brain barrier (BBB), diffus...
| Published in: | Pharmaceutics |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/6/688 |